welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Coxib-inhibition of Duodenal Polyp Growth in FAP
study id #: NCT00844727
condition: Duodenal Polyposis
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
start date: September 2003
estimated completion: April 2004
last updated: July 6, 2011
phase of development: Phase 2, Phase 3
size / enrollment: 38
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- FAP patient with previous colectomy and confirmed polyposis
- NSAID hypersensitivity
expertly curated content related to this topic
- Practical guide to exocrine pancreatic insufficiency – Breaking the mythsBACKGROUND: Exocrine pancreatic insuf...
- Colorectal Polyposis: Clinical Presentation and Surgical TreatmentKEYWORDS: colorectal cancer; colorectal...
- The J-Pouch Group Dietary GuidelinesGood nutrition plays an essential role i...
- Endomicrocancer: Confocal Endomicroscopy in Patients With High Risk of Colorectal CancerThe principle objective of this study is...
- The Wnt/Beta-Catenin Pathway and Familial Adenomatous Polyposis Part 2https://www.youtube.com/watch?v=p2mWc0IG...
- Familial Adenomatous Polyposis in Pediatrics: Natural History, Emerging Surveillance and Management Protocols, Chemo...Familial adenomatous polyposis (FAP) is ...
- Complete Rectosigmoid Prolapse in a Patient with Familial Adenomatous PolyposisColonoscopy in a 23-year-old woman to ev...